Jade Biosciences, Inc. · NASDAQ:JBIO
The Vanguard Group reported a 5.60% stake in Jade Biosciences, Inc. (Schedule 13G)
Event Jun 30, 2025 · Filed Jul 29, 2025
The Vanguard Group reported a 5.60% stake in Jade Biosciences, Inc., 1,807,582 shares, as a passive investor on Jun 30, 2025. Filed Jul 29, 2025 (Schedule 13G).
- Stake
- 5.60%
- Shares
- 1,807,582
- Intent
- Passive
- What changed
- Crossed above 5%
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| The Vanguard Group | 5.60% | 1,807,582 |
Source
Related
- Jade Biosciences, Inc.
- The Vanguard Group
- Jade Biosciences, Inc. shareholders
- Schedule 13G/A · The Vanguard Group · Jan 30, 2026
- Schedule 13G/A · Venrock Healthcare Capital Partners III, L.P. · Aug 14, 2026
- Schedule 13G/A · Bellevue Group AG · Aug 14, 2026
- Schedule 13G · Paradigm Biocapital Advisors LP · Jul 17, 2026
- Schedule 13G/A · Janus Henderson Group PLC · Jul 8, 2026
- Schedule 13D/A · Fairmount Funds Management LLC · Jun 9, 2026